MMP9 and metastatic melanoma: We also found that the circulating levels of MPO (Fig. 7d), MMP-9 (Fig. 7e), GM-CSF (Fig. 7f) and CXCL8/IL-8 (Fig. 7g) were higher in metastatic melanoma patients than in healthy controls.